Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14651264rdf:typepubmed:Citationlld:pubmed
pubmed-article:14651264lifeskim:mentionsumls-concept:C0043552lld:lifeskim
pubmed-article:14651264lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:14651264lifeskim:mentionsumls-concept:C0024432lld:lifeskim
pubmed-article:14651264lifeskim:mentionsumls-concept:C0001511lld:lifeskim
pubmed-article:14651264lifeskim:mentionsumls-concept:C0031308lld:lifeskim
pubmed-article:14651264lifeskim:mentionsumls-concept:C0013878lld:lifeskim
pubmed-article:14651264lifeskim:mentionsumls-concept:C0596543lld:lifeskim
pubmed-article:14651264lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:14651264lifeskim:mentionsumls-concept:C1523308lld:lifeskim
pubmed-article:14651264pubmed:issue2lld:pubmed
pubmed-article:14651264pubmed:dateCreated2003-12-3lld:pubmed
pubmed-article:14651264pubmed:abstractTextPhagocytosis by macrophages is most important in the initial stages of an immune response. Although RhoA regulates cell adhesion, its roles in the integrin-related association of particles with macrophages and in phagocytosis are not clearly understood. We introduced C3 exoenzyme, a specific inhibitor of Rho, into J774A.1 macrophage cells fused with the 9 amino acid (49-57) transduction domain (RKKRRQRRR) of HIV-1 Tat. The presence of this Tat-C3 vector altered RhoA mobility on non-denaturing gels, indicating that Tat-C3 modified RhoA by ADP-ribosylation. Uptake of (FITC)-conjugated serum-opsonized zymosan particles and adhesion to fibrinogen-coated plates were reduced as was the association of serum-opsonized zymosan particles, and complement C3 and C3bi with the transfected cells. These results suggest that Rho regulates the activity of integrins that are involved in the association of particles with macrophages, phagocytosis, adhesion, and binding of complement C3 and C3bi.lld:pubmed
pubmed-article:14651264pubmed:languageenglld:pubmed
pubmed-article:14651264pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:citationSubsetIMlld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14651264pubmed:statusMEDLINElld:pubmed
pubmed-article:14651264pubmed:monthOctlld:pubmed
pubmed-article:14651264pubmed:issn1016-8478lld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:ChoiSoo...lld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:ParkJinseuJlld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:KimJong-IlJIlld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:ParkJae-BongJ...lld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:KimJun-SubJSlld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:LeeJae-YongJYlld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:KimJaebongJlld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:JungKyeong-Ch...lld:pubmed
pubmed-article:14651264pubmed:authorpubmed-author:LeeHak-JuHJlld:pubmed
pubmed-article:14651264pubmed:issnTypePrintlld:pubmed
pubmed-article:14651264pubmed:day31lld:pubmed
pubmed-article:14651264pubmed:volume16lld:pubmed
pubmed-article:14651264pubmed:ownerNLMlld:pubmed
pubmed-article:14651264pubmed:authorsCompleteYlld:pubmed
pubmed-article:14651264pubmed:pagination216-23lld:pubmed
pubmed-article:14651264pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:meshHeadingpubmed-meshheading:14651264...lld:pubmed
pubmed-article:14651264pubmed:year2003lld:pubmed
pubmed-article:14651264pubmed:articleTitleExoenzyme Tat-C3 inhibits association of zymosan particles, phagocytosis, adhesion, and complement binding in macrophage cells.lld:pubmed
pubmed-article:14651264pubmed:affiliationDepartment of Genetic Engineering, Division of Life Sciences, Hallym University, Chunchon 200-702, Korea. jbpark@hallym.ac.krlld:pubmed
pubmed-article:14651264pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14651264pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14651264lld:pubmed